logo
logo

Radar Therapeutics Raises $13.4M in Seed Funding Led by NfX Bio to Develop Smart Programmable Medicines Using Molecular RNA Sensors

May 23, 2024about 1 year ago

Amount Raised

$13.4 Million

Round Type

seed

BerkeleyBiotechnologyHealth Care

Investors

BevcPear VcKd T VenturesBiovision VenturesEli Lilly And CompanyNf X Bio

Description

Radar Therapeutics, a biotech company, has completed an oversubscribed $13.4 million in seed financing led by NfX Bio. The funding will support the advancement of Radar’s internal programs, team expansion, and partnering.

Company Information

Company

Radar Therapeutics

Location

Berkeley, California, United States

About

Radar Therapeutics is a biotech company developing programmable precision therapeutics. Leveraging innovative mRNA technology and proprietary regulatory control elements, the company aims to revolutionize medicine by enabling targeted, timely, and controlled therapeutic interventions. Radar is committed to advancing the boundaries of genetic medicine to address unmet medical needs and improve patient access. The company is based in Berkeley, CA. For more information, visit www.radartx.bio.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People